In an era of widespread genetic sequencing, the ability to edit and alter an organism’s DNA is a powerful way to explore the information within and how it guides biological function.
A paper from the University of Wisconsin-Madison in the August issue of the journal GENETICS takes genome editing to a new level in fruit flies, demonstrating a remarkable level of fine control and, importantly, the transmission of those engineered genetic changes across generations.
Both features are key for driving the utility and spread of an approach that promises to give researchers new insights into the basic workings of biological systems, including embryonic development, nervous system function, and the understanding of human disease.
“Genome engineering allows you to change gene function in a very targeted way, so you can probe function at a level of detail” that wasn’t previously possible, says Melissa Harrison, an assistant professor of biomolecular chemistry in the UW-Madison School of Medicine and Public Health and one of the three senior authors of the new study.
Disrupting individual genes has long been used as a way to study their roles in biological function and disease. The new approach, based on molecules that drive a type of bacterial immune response, provides a technical advance that allows scientists to readily engineer genetic sequences in very detailed ways, including adding or removing short bits of DNA in chosen locations, introducing specific mutations, adding trackable tags, or changing the sequences that regulate when or where a gene is active.
The approach used in the new study, called the CRISPR RNA/Cas9 system, has developed unusually fast. First reported just one year ago by scientists at the Howard Hughes Medical Institute and University of California, Berkeley, it has already been applied to most traditional biological model systems, including yeast, zebrafish, mice, the nematode C. elegans, and human cells. The Wisconsin paper was the first to describe it in fruit flies and to show that the resulting genetic changes could be passed from one generation to the next.
“There was a need in the community to have a technique that you could use to generate targeted mutations,” says Jill Wildonger, a UW-Madison assistant professor of biochemistry and another senior author of the paper. “The need was there and this was the technical advance that everyone had been waiting for.”
“The reason this has progressed so quickly is that many researchers — us included — were working on other, more complicated, approaches to do exactly the same thing when this came out,” adds genetics assistant professor Kate O’Connor-Giles, the third senior author. “This is invaluable for anyone wanting to study gene function in any organism and it is also likely to be transferable to the clinical realm and gene therapy.”
The CRISPR RNA/Cas9 system directs a DNA-clipping enzyme called Cas9 to snip the DNA at a targeted sequence. This cut then stimulates the cell’s existing DNA repair machinery to fill in the break while integrating the desired genetic tweaks. The process can be tailored to edit down to the level of a single base pair — the rough equivalent of changing a single letter in a document with a word processor.
The broad applicability of the system is aided by a relatively simple design that can be customized through creation of a short RNA sequence to target a specific sequence in the genome to generate the desired changes. Previous genome editing methods have relied on making custom proteins, which is costly and slow.
“This is so readily transferable that it’s highly likely to enable gene knockout and other genome modifications in any organism,” including those that have not previously been used for laboratory work, says O’Connor-Giles. “It’s going to turn non-model organisms into genetic model organisms.”
That ease may also pay off in the clinic. “It can be very difficult and time-consuming to generate models to study all the gene variants associated with human diseases,” says Wildonger. “With this genome editing approach, if we work in collaboration with a clinician to find [clinically relevant] mutations, we can rapidly translate these into a fruit fly model to see what’s happening at the cellular and molecular level.”
The Latest on: Genome editing
- In vivo genome editing rescues photoreceptor degeneration via a Cas9/RecA-mediated homology-directed repair pathway on April 17, 2019 at 12:28 pm
1 Hefei National Laboratory for Physical Sciences at the Microscale, Neurodegenerative Disorder Research Center, Chinese Academy of Sciences Key Laboratory of Brain Function and Disease, School of ... […]
- CRISPR edits lung-disease gene in utero, hitting only the affected organ in a mouse study on April 17, 2019 at 11:16 am
Companies that hope to treat severe inherited diseases via CRISPR genome editing are already testing the technique in adults, while push-the-envelope types are arguing for repairing defective genes ... […]
- Stanford clears faculty members in gene-edited baby inquiry on April 17, 2019 at 10:37 am
FILE - In this Wednesday, Nov. 28, 2018 file photo, He Jiankui speaks during the Human Genome Editing Conference in Hong Kong. On Tuesday, April 17, 2019, Stanford University said they had cleared ... […]
- Transparency and trust: Is there room for ‘the people’ in the human gene editing debate? on April 17, 2019 at 10:25 am
At the same time, a quorum of leading scientists recently called for a moratorium on “heritable genome editing” similarly in the interests of promoting “transparency” and to curtail “ero ... […]
- Genome Editing Market Business Opportunities, Application Analysis, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2017 – 2025 on April 17, 2019 at 1:42 am
The genome editing market was valued at US$ 3,210.1 in 2017 and is expected to reach US$ 10,691.0 Mn in 2025. The market is estimated to grow with a CAGR of 17.0% from 2017-2025. The report includes ... […]
- European Trends: Genome Editing Market to grow at a CAGR of 16.7% by 2025 - Regional Analysis and Forecasts on April 17, 2019 at 1:02 am
European Court of Justice Ruling on Genome Editing: Recently, under the EU regulation on genetically modified organisms the judgment is passed through the European Court of Justice that gene ... […]
- CasX: a new and small CRISPR gene-editing protein on April 16, 2019 at 1:15 pm
demonstrate the DNA cleavage characteristics of CasX (a newly identified dual-RNA-guided DNA targeting nuclease) and establish its capacity for genome editing in Escherichia coli and human cells. ... […]
- Generation of herbicide tolerance traits and a new selectable marker in wheat using base editing on April 15, 2019 at 11:55 am
Developing herbicide-tolerant varieties by genome editing holds great promise for addressing the worsening weed problems in wheat cultivation 1. Here, we generated transgene-free wheat germplasms ... […]
- Human Gene Editing is Controversial. Shoukhrat Mitalipov Isn't Deterred on April 15, 2019 at 9:58 am
Chinese researcher He Jiankui’s announcement last November came on the eve of the International Summit on Human Genome Editing in Hong Kong. He was scheduled to give a talk on his work shortly after ... […]
- He Jiankui, embryo editing, CCR5, the London patient, and jumping to conclusions on April 15, 2019 at 2:03 am
and a worldwide scientific consensus against human germline genome editing, built in publications and statements over more than three and a half years, had been ignored. He’s stated goal was to give ... […]
via Google News and Bing News